Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 72.00
+0.25 (0.35%)
Aug 1, 2025, 4:08 PM HKT
Revance Therapeutics Market Cap
HKG:6855 has a market cap or net worth of 26.77 billion as of August 1, 2025. Its market cap has increased by 221.11% in one year.
Market Cap
26.77B
Enterprise Value
27.21B
Revenue
1.04B
Ranking
n/a
PE Ratio
n/a
Stock Price
$72.00
Market Cap Chart
Since October 28, 2019, HKG:6855's market cap has increased from 7.59B to 26.77B, an increase of 252.85%. That is a compound annual growth rate of 24.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 26.77B | 90.27% |
| Dec 31, 2024 | 14.07B | 81.16% |
| Dec 29, 2023 | 7.77B | 17.12% |
| Dec 30, 2022 | 6.63B | -8.70% |
| Dec 31, 2021 | 7.26B | -14.53% |
| Dec 31, 2020 | 8.50B | 39.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 284.77B |
| Hansoh Pharmaceutical Group Company | 216.43B |
| Innovent Biologics | 168.29B |
| JD Health International | 160.81B |
| Akeso | 137.15B |
| WuXi Biologics | 135.91B |
| Sino Biopharmaceutical | 134.49B |
| CSPC Pharmaceutical Group | 115.47B |